Old Web
English
Sign In
Acemap
>
authorDetail
>
Christina Treppendahl
Christina Treppendahl
Medicine
Migraine
Family medicine
Adverse effect
Tolerability
4
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
2021
Headache
Todd J. Schwedt
Joseph G. Hentz
Soma Sahai-Srivastava
Nicole M. Spare
Vincent T. Martin
Christina Treppendahl
Kathleen B. Digre
Nathan L. Bennett
Marius Birlea
David Watson
Natalia Murinova
Teri Robert
David W. Dodick
Show All
Source
Cite
Save
Citations (3)
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials.
2021
Neurology and Therapy
Susan Hutchinson
David W. Dodick
Christina Treppendahl
Nathan L. Bennett
Sung Yun Yu
Hua Guo
Joel M. Trugman
Show All
Source
Cite
Save
Citations (1)
Ubrogepant for the Acute Treatment of Migraine: Pooled Safety and Tolerability From ACHIEVE I and ACHIEVE II Phase 3 Studies (117)
2020
Neurology
Susan Hutchinson
David W. Dodick
Christina Treppendahl
Nathan L. Bennett
Sung Yun Yu
Hua Guo
Joel M. Trugman
Show All
Source
Cite
Save
Citations (0)
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations
2017
The American Journal of Managed Care
Stephen D. Silberstein
Anne H. Calhoun
Christina Treppendahl
David William Dodick
Alan M. Rapoport
Avinash Mamidi
Peter Vargas
Thomas H. Ebert
Stewart J. Tepper
Show All
Source
Cite
Save
Citations (2)
1